Galapagos

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Galapagos and other ETFs, options, and stocks.

About GLPG

Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic pulmonary fibrosis. 

CEO
Henry O. Gosebruch
CEOHenry O. Gosebruch
Employees
704
Employees704
Headquarters
Mechelen, Brussels Region
HeadquartersMechelen, Brussels Region
Founded
1999
Founded1999
Employees
704
Employees704

GLPG Key Statistics

Market cap
2.15B
Market cap2.15B
Price-Earnings ratio
6.05
Price-Earnings ratio6.05
Dividend yield
Dividend yield
Average volume
137.61K
Average volume137.61K
High today
$33.12
High today$33.12
Low today
$32.19
Low today$32.19
Open price
$33.12
Open price$33.12
Volume
41.68K
Volume41.68K
52 Week high
$37.78
52 Week high$37.78
52 Week low
$22.59
52 Week low$22.59

GLPG News

TipRanks 20h
Galapagos Discloses Bank of America’s Stake Drop Below 5% Threshold

An announcement from Galapagos ( (GLPG) ) is now available. On March 17, 2026, Galapagos NV reported that it had received a transparency notification from Bank...

Analyst ratings

55%

of 11 ratings
Buy
18.2%
Hold
54.5%
Sell
27.3%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.